BCL6 Antibody

CAT:
223-6985-01
Size:
0.02 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
BCL6 Antibody - image 1

BCL6 Antibody

  • Background:

    BCL6 Antibody: BCL6 was first identified as a proto-oncogene in diffuse large B cell lymphoma. BCL6, a transcriptional repressor, plays an important role in lymphomagenesis. It binds Stat recognition-like DNA elements and is required for affinity maturation of mature B cells in germinal centers and Th1/Th2 differentiation, a process that critically depends on BCL6-mediated transcriptional repression of p53. BCL6 is a pharmacological target for eradication of leukemia-initiating cells in chronic myeloid leukemia (CML) .
  • NCBI Gene ID:

    604
  • Swiss Prot:

    P41182
  • Accession Number:

    NP_001124317
  • Host:

    Rabbit
  • Reactivity:

    Human, Mouse, Rat
  • Clonality:

    Polyclonal
  • Conjugation:

    Unconjugated
  • Type:

    Primary Antibodies
  • Field of Research:

    Cancer, Cell Cycle
  • Purification:

    BCL6 Antibody is affinity chromatography purified via peptide column.
  • Positive Control:

    Cat. No. 1462 - Rat Lung Tissue Lysate
  • Concentration:

    1 mg/mL
  • Buffer:

    BCL6 Antibody is supplied in PBS containing 0.02% sodium azide.
  • Modification:

    None
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    BCL6 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
  • Calculated Molecular Weight:

    78 kDa
  • Fragment:

    IgG
  • Specificity:

    Three alternatively spliced transcript variants have been observed
  • Symbol:

    BCL6
  • NCBI Official Name:

    B-cell CLL/lymphoma 6
  • NCBI Organism:

    Homo sapiens
  • Background Reference 01:

    Ye BH, Chaganti S, Chang CC, et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J. 1995; 14:6209-17.
  • Background Reference 02:

    Dent AL, Shaffer AL, Yu X, et al. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science1997; 276:589-92.
  • Background Reference 03:

    Ye BH, Cattoretti G, Shen Q, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 1997; 16:161-70.
  • Background Reference 04:

    Hurtz C, Hatzi K, Cerchietti L, et al. BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia. J. Exp. Med. 2011; 208:2163-74.
  • Other Product Names:

    BCL6 Antibody: BCL5, LAZ3, BCL6A, ZNF51, ZBTB27, BCL5, B-cell lymphoma 6 protein, B-cell lymphoma 5 protein, BCL-6
  • Tested Applications:

    ELISA, WB
  • Protein ID:

    195927002
  • Physical Properties:

    Liquid